Has Steven Stevens, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,009 in general payments to Steven Stevens, MD across 164 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Stevens, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Stevens, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Stevens, MD

Clinical Cardiac Electrophysiology · Bethlehem, PANPI 1588827091

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 54.7% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in PA, where the typical reported total is $15,643.

$18,009in general payments, 2019–2025

Across 164 payments — averaging $109.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$10K
Impulse Dynamics (USA) Inc.$3K
Boston Scientific$2K
Abbott$2K
Edwards Lifesciences$328
Biosense Webster, Inc.$169
plus $207 from 4 others

$90,780in research payments, 2019–2025

Across 49 payments — averaging $1852.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Impulse Dynamics (USA) Inc.$41K
Abbott$33K
Janssen Research & Development, LLC$16K

What the payments were for

Speaking & faculty fees$5,40030%
Travel & lodging$5,74432%
Food & beverage$6,86538%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	103	$9,845
Impulse Dynamics (USA) Inc.	2	$3,157
Boston Scientific	29	$2,168
Abbott	19	$2,135
Edwards Lifesciences	2	$328
Biosense Webster, Inc.	5	$169
Inspire Medical Systems, Inc.	1	$125
Biotronik Inc.	1	$28
E.r. Squibb & Sons, L.L.C.	1	$28
GE HealthCare	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OPTIMIZER$6,314
Azure$1,380
AVEIR$1,337
Rhythmia Mapping System$1,259
Micra$436
SAPIEN 3 Ultra RESILIA$328
COBALT DR MRI SURESCAN$304
COREVALVE EVOLUT R$278
PulseSelect$243
ENSITE$166
SelectSecure$161
Visia AF$140
MyCareLink$127
Ensite Cardiac Mapping System$125
Inspire Upper Airway Stimulation System$125
WATCHMAN Access System$125
TYRX$116
Carto 3$111
AZURE XT DR MRI SURESCAN$110
JOT DX$101

How this compares

$18,009 in reported general payments places this provider in the 50th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$334,663

Medicare patients

1,201

Services billed

3,956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	375	$360,494
XareltoRivaroxaban	117	$131,783
EntrestoSacubitril/Valsartan	14	$15,845
Dofetilide	92	$8,025
Metoprolol Succinate	381	$7,680
Dabigatran EtexilateDabigatran Etexilate Mesylate	18	$5,358
Amiodarone Hcl	66	$4,198
Flecainide Acetate	97	$3,743
Propranolol Hcl ErPropranolol Hcl	60	$2,379
SotalolSotalol Hcl	93	$2,298
Propafenone Hcl	48	$2,257
Potassium Chloride	49	$1,891
Nebivolol Hcl	18	$1,478
Dilt-XrDiltiazem Hcl	21	$1,222
Atorvastatin Calcium	104	$1,196

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Bethlehem

Seth WorleyLancaster$3.7M
John ChenaridesPittsburgh$750K
Fermin GarciaPhiladelphia$684K
Ralph VerdinoPhiladelphia$682K
Pugazhendhi VijayaramanWilkes Barre$594K
Pasquale SantangeliPhiladelphia$581K
Joshua SilversteinPittsburgh$557K
Francis MarchlinskiPhiladelphia$469K
Joshua CooperPhiladelphia$405K
Timothy MarkmanPhiladelphia$402K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →